Xue Ying

2.5k total citations
47 papers, 2.0k citations indexed

About

Xue Ying is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Xue Ying has authored 47 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Biomaterials. Recurrent topics in Xue Ying's work include RNA Interference and Gene Delivery (11 papers), Nanoparticle-Based Drug Delivery (8 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Xue Ying is often cited by papers focused on RNA Interference and Gene Delivery (11 papers), Nanoparticle-Based Drug Delivery (8 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Xue Ying collaborates with scholars based in China, United States and South Korea. Xue Ying's co-authors include Wan-Liang Lü, Ju Du, Jinning Lou, Ying Men, Ruo‐Jing Li, Wei Tian, Jia Guo, Qiang Zhang, Ge Zhang and Xinru Jia and has published in prestigious journals such as Angewandte Chemie International Edition, Biomaterials and Analytical Chemistry.

In The Last Decade

Xue Ying

44 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xue Ying China 21 1.1k 648 467 307 184 47 2.0k
Nongnuj Muangsin Thailand 28 782 0.7× 665 1.0× 436 0.9× 164 0.5× 110 0.6× 95 2.7k
Rezvan Yazdian‐Robati Iran 28 1.2k 1.2× 365 0.6× 656 1.4× 192 0.6× 56 0.3× 77 2.0k
Wenli Zhang China 34 891 0.8× 716 1.1× 579 1.2× 210 0.7× 56 0.3× 99 2.6k
Orazio Vittorio Italy 32 606 0.6× 832 1.3× 1.1k 2.4× 278 0.9× 97 0.5× 108 3.1k
Xiang Gao China 31 1.1k 1.1× 758 1.2× 704 1.5× 453 1.5× 68 0.4× 95 2.8k
Ji Zhang China 34 2.1k 2.0× 261 0.4× 433 0.9× 356 1.2× 139 0.8× 227 4.5k
Masoud Torkzadeh‐Mahani Iran 34 1.3k 1.2× 429 0.7× 528 1.1× 551 1.8× 182 1.0× 116 3.3k
Chengli Yang China 26 673 0.6× 512 0.8× 914 2.0× 136 0.4× 58 0.3× 85 2.0k
Antonella Leggio Italy 28 966 0.9× 218 0.3× 292 0.6× 218 0.7× 39 0.2× 103 2.1k
Saman Sargazi Iran 34 1.2k 1.2× 684 1.1× 960 2.1× 214 0.7× 101 0.5× 155 3.2k

Countries citing papers authored by Xue Ying

Since Specialization
Citations

This map shows the geographic impact of Xue Ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Ying more than expected).

Fields of papers citing papers by Xue Ying

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Ying. The network helps show where Xue Ying may publish in the future.

Co-authorship network of co-authors of Xue Ying

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Ying. A scholar is included among the top collaborators of Xue Ying based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Ying. Xue Ying is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Qiulan, Yan Chen, Yi Luo, et al.. (2025). Nanoparticles co-loaded with sorafenib and emodin: preparation and efficacy against liver cancer in vitro and in vivo. Pharmaceutical Development and Technology. 30(4). 450–462.
2.
3.
Liang, Yi, et al.. (2024). Targeted Liposomal Co-Delivery Dopamine with 3-n-Butylphthalide for Effective Against Parkinson’s Disease in Mice Model. International Journal of Nanomedicine. Volume 19. 12851–12870.
4.
Xiong, Yan, Lingfeng Tang, Wenhao Shi, et al.. (2023). A liposomal etoposide with a sustained drug release effectively alleviated the therapy-related leukemia. International Journal of Pharmaceutics. 646. 123437–123437. 3 indexed citations
5.
Guo, Xiaohan, Yi Wu, Xue Ying, Na Xie, & Guobo Shen. (2023). Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatment. Frontiers in Immunology. 14. 1291836–1291836. 15 indexed citations
6.
Ying, Xue, et al.. (2023). An overview of DNA methylation markers for early detection of gastric cancer: current status, challenges, and prospects. Frontiers in Genetics. 14. 1234645–1234645. 2 indexed citations
7.
Li, Peng, Xiaoya Zheng, Xue Ying, et al.. (2023). Central lymph nodes in frozen sections can effectively guide extended lymph node resection for papillary thyroid carcinoma. Annals of Medicine. 55(2). 2286337–2286337. 2 indexed citations
8.
Zhang, Qian, Hongqing Zhu, Hua Zhang, et al.. (2021). Systems Pharmacology–Based Dissection of Anti-Cancer Mechanism of Traditional Chinese Herb Saussurea involucrata. Frontiers in Pharmacology. 12. 678203–678203. 7 indexed citations
9.
Huang, Yang, et al.. (2019). Task-specific ionic liquid-enabled mercury sensor for sensitive detection of total mercury in food digestion solution. Sensors and Actuators B Chemical. 285. 62–67. 21 indexed citations
10.
Ying, Xue, Xiao Han, Songhe Guo, et al.. (2018). Indoleamine 2,3-dioxygenase expression regulates the survival and proliferation of Fusobacterium nucleatum in THP-1-derived macrophages. Cell Death and Disease. 9(3). 355–355. 72 indexed citations
11.
Ying, Xue, et al.. (2017). The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals. International Journal of Nanomedicine. Volume 12. 1369–1384. 70 indexed citations
12.
Fan, Sai, et al.. (2017). [Detection method of phthalate esters and their metabolites in blood].. PubMed. 46(2). 309–317. 1 indexed citations
14.
Ning, Fen, et al.. (2016). iRGD-targeted delivery of a pro-apoptotic peptide activated by cathepsin B inhibits tumor growth and metastasis in mice. Tumor Biology. 37(8). 10643–10652. 26 indexed citations
15.
Liao, Yuehua, et al.. (2015). Higher heat shock factor 1 expression in tumor stroma predicts poor prognosis in esophageal squamous cell carcinoma patients. Journal of Translational Medicine. 13(1). 338–338. 29 indexed citations
16.
Ying, Xue, et al.. (2013). Poly(pyrocatechol-3,5-disodiumsulfonate)/Multi-Walled Carbon Nanotubes Composite for Simultaneous Determination of Dopamine, Ascorbic Acid and Uric Acid. Journal of Nanoscience and Nanotechnology. 13(2). 1563–1568. 4 indexed citations
17.
Zhao, Hong, et al.. (2011). Determination of Cu<SUP>2+</SUP> Using Poly(2-aminothiazole)/Multi-Walled Carbon Nanotubes Composite Film Modified Glassy Carbon Electrodes. Journal of Nanoscience and Nanotechnology. 11(4). 3381–3384. 4 indexed citations
18.
He, Hai, Li Y, Xinru Jia, et al.. (2010). PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors. Biomaterials. 32(2). 478–487. 245 indexed citations
19.
Li, Ruo‐Jing, Xue Ying, Yan Zhang, et al.. (2010). All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells. Journal of Controlled Release. 149(3). 281–291. 102 indexed citations
20.
Ying, Xue, He Wen, Wan-Liang Lü, et al.. (2009). Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. Journal of Controlled Release. 141(2). 183–192. 358 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026